Follow
iacopo olivotto
iacopo olivotto
Cardiomyopathy Unit, Careggi University Hospital, Florence
Verified email at aou-careggi.toscana.it
Title
Cited by
Cited by
Year
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy
MS Maron, I Olivotto, S Betocchi, SA Casey, JR Lesser, MA Losi, F Cecchi, ...
New England Journal of Medicine 348 (4), 295-303, 2003
17212003
Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction
S Grifoni, I Olivotto, P Cecchini, F Pieralli, A Camaiti, G Santoro, A Conti, ...
Circulation 101 (24), 2817-2822, 2000
12072000
Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction
MS Maron, I Olivotto, AG Zenovich, MS Link, NG Pandian, JT Kuvin, ...
Circulation 114 (21), 2232-2239, 2006
11852006
Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy
I Olivotto, F Cecchi, SA Casey, A Dolara, JH Traverse, BJ Maron
Circulation 104 (21), 2517-2524, 2001
10512001
Epidemiology of hypertrophic cardiomyopathy–related death: revisited in a large non–referral-based patient population
BJ Maron, I Olivotto, P Spirito, SA Casey, P Bellone, TE Gohman, ...
Circulation 102 (8), 858-864, 2000
10382000
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy
RH Chan, BJ Maron, I Olivotto, MJ Pencina, GE Assenza, T Haas, ...
Circulation 130 (6), 484-495, 2014
9842014
2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)
E Arbelo, A Protonotarios, JR Gimeno, E Arbustini, R Barriales-Villa, ...
European heart journal 44 (37), 3503-3626, 2023
9032023
Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy
F Cecchi, I Olivotto, R Gistri, R Lorenzoni, G Chiriatti, PG Camici
New England Journal of Medicine 349 (11), 1027-1035, 2003
8992003
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy
SR Ommen, BJ Maron, I Olivotto, MS Maron, F Cecchi, S Betocchi, ...
Journal of the American College of Cardiology 46 (3), 470-476, 2005
8902005
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, ...
The Lancet 396 (10253), 759-769, 2020
8702020
Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine
BJ Maron, SR Ommen, C Semsarian, P Spirito, I Olivotto, MS Maron
Journal of the American College of Cardiology 64 (1), 83-99, 2014
7402014
Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
CY Ho, SM Day, EA Ashley, M Michels, AC Pereira, D Jacoby, AL Cirino, ...
Circulation 138 (14), 1387-1398, 2018
6652018
Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance
MS Maron, BJ Maron, C Harrigan, J Buros, CM Gibson, I Olivotto, L Biller, ...
Journal of the American College of Cardiology 54 (3), 220-228, 2009
5712009
Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy
I Olivotto, MS Maron, AS Adabag, SA Casey, D Vargiu, MS Link, ...
Journal of the American College of Cardiology 46 (3), 480-487, 2005
4992005
Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy
BJ Maron, I Olivotto, P Bellone, MR Conte, F Cecchi, BP Flygenring, ...
Journal of the American College of Cardiology 39 (2), 301-307, 2002
4842002
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
DA Hughes, K Nicholls, SP Shankar, G Sunder-Plassmann, D Koeller, ...
Journal of medical genetics 54 (4), 288-296, 2017
4762017
Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy
MS Maron, I Olivotto, C Harrigan, E Appelbaum, CM Gibson, JR Lesser, ...
Circulation 124 (1), 40-47, 2011
4682011
Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport …
A Pelliccia, EE Solberg, M Papadakis, PE Adami, A Biffi, S Caselli, ...
European Heart Journal 40 (1), 19-33, 2019
4642019
Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy
I Olivotto, F Girolami, MJ Ackerman, S Nistri, JM Bos, E Zachara, ...
Mayo Clinic Proceedings 83 (6), 630-638, 2008
4552008
Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy
R Coppini, C Ferrantini, L Yao, P Fan, M Del Lungo, F Stillitano, L Sartiani, ...
Circulation 127 (5), 575-584, 2013
4422013
The system can't perform the operation now. Try again later.
Articles 1–20